跳至主要内容
临床试验/CTRI/2023/08/056469
CTRI/2023/08/056469尚未招募Phase 3 4

A cinical study of Ksheerbala Taila Abhyanga and Ksheerabala Taila Nasya in the management of Anidra(Insomnia)

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年8月21日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
to assess the effect of ksheerbala taila by abhyanga & nasya in the management of anidra (insomnia) by PITTSBURGH SLEEP QUALITY INDEX

研究概览

简要总结

This study is single arm, an open label trial, with single group of 30 patients to assess the efficacy of  ksheerbala taila by abhyanga and nasya in the management of anidra (insomnia). The primary objective of present study is reducing subjective parameter -Jrimbha (Yawning), Tandra (Drowsiness),   Angamarda/Angasada (Malaise), Arati/ Klama (Fatigue & inertness)   Sirahshools (Headache),  Manodourbalya (Lack of concentration),  Smiritidourbaliya (Loss of memory),  Indriya karmahani (Poor sensory perception),   Ajirna /Agnimandhya (Indigestion),   Malabaddhata (Constipation),   Dhatu kshaya (Weight loss),  Kanti kshaya (Loss of luster) usimg PITTSBURGH SLEEP QUALITY INDEX. Abhang in 7 position  and Nasya in the dosage of  6 -6 drops will be done for 14 days using Ksheerbala Taila.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • a)Diagnosed and confirmed cases of insomina, as per Case Report Form & on the basis of the sign & symptoms.
  • b)Individual between the age group of 18 to 70 of both sexes having insomnia.
  • c)Insomnia with mild hypertensions d)Insomnia with mild depression and anxiety disorders without any complications of any other disease.

排除标准

  • a)Patients below 18years and above 70 years of age.
  • b)Major psychiatric illness like schizophrenia, depression, epilepsy etc not registered.
  • c)Alcohol dependency & drugs dependency excluded.
  • d)Chronic illness like asthma, renal failure, diabetes etc excluded.
  • e)Acute illness like cerebro-vascular accidents, congestive cardiac failure, myocardial infarction, chronic obstructive pulmonary disease and similar other disorders excluded.

结局指标

主要结局

to assess the effect of ksheerbala taila by abhyanga & nasya in the management of anidra (insomnia) by PITTSBURGH SLEEP QUALITY INDEX

时间窗: 30 DAYS

次要结局

  • To improve the quality of life.(30 DAYS)

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验